The effect of patient's body weight, infusion connection point, and infusion pump position on intravenous multi-infusion drug delivery at low infusion rates suitable for premature neonates.

dosing error drug delivery infusion pump intravenous infusion neonate

Journal

The Journal of pharmacy and pharmacology
ISSN: 2042-7158
Titre abrégé: J Pharm Pharmacol
Pays: England
ID NLM: 0376363

Informations de publication

Date de publication:
02 Dec 2023
Historique:
received: 13 07 2023
accepted: 06 11 2023
medline: 2 12 2023
pubmed: 2 12 2023
entrez: 2 12 2023
Statut: aheadofprint

Résumé

Parenteral drug administration in the neonatal intensive care involves complex pharmacotherapy adjusted for the patient's weight, fluid allowance, and complex multi-infusion systems. We investigated the delivery rate of a model drug through a multi-infusion system consisting of six intravenous infusions. Delivery rate of the model drug was determined after infusion initiation and termination. Measurements were collected spectrophotometrically in real time. Time to drug delivery and the amount of drug delivered were measured. The longest time to drug delivery was observed for a 500 g neonate model with a distal infusion connection point and neutral pump position (337 ± 30 min, P < 0.001). The shortest time was observed for a 1000 g neonate model in the combination of proximal infusion connection point and neutral pump position (18 ± 12 min, P < 0.05). The expected 100% of the drug was delivered only in two combinations: 500 g and 1000 g neonate models, proximal infusion connection point and neutral pump position (100.4 ± 4.7%, P = 0.819 and 100.2 ± 2.7%, P = 0.874, respectively). While the least drug was delivered to a 500 g neonate model in the combination of distal infusion connection point and neutral pump position (27.5 ± 5.8%, P < 0.001). Delayed drug delivery to premature neonates due to multi-infusion systems may compromise accurate drug administration and lead to dosing errors.

Identifiants

pubmed: 38041860
pii: 7458091
doi: 10.1093/jpp/rgad108
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : School of Pharmacy and Biomolecular Science
Organisme : Rotunda Foundation
ID : RF/RH/2020/06
Organisme : B. Braun Ireland Ltd

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the Royal Pharmaceutical Society.

Auteurs

Kamelia Krysiak (K)

The Rotunda Hospital, Parnell Square, Dublin, D01 P5W9, Ireland.
School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin, D02 H903, Ireland.

Brian Cleary (B)

The Rotunda Hospital, Parnell Square, Dublin, D01 P5W9, Ireland.
School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin, D02 H903, Ireland.

Naomi McCallion (N)

The Rotunda Hospital, Parnell Square, Dublin, D01 P5W9, Ireland.
School of Medicine, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin, D02 H903 Ireland.

Fiona O'Brien (F)

School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin, D02 H903, Ireland.

Classifications MeSH